We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Novel Coronavirus Imaging Shows “Significant Overlap” With SARS and MERS

Novel Coronavirus Imaging Shows “Significant Overlap” With SARS and MERS

Novel Coronavirus Imaging Shows “Significant Overlap” With SARS and MERS

Novel Coronavirus Imaging Shows “Significant Overlap” With SARS and MERS

A and B, Initial CT images obtained show small round areas of mixed ground-glass opacity and consolidation (rectangles) at level of aortic arch (A) and ventricles (B) in right and left lower lobe posterior zones. C and D, Follow-up CT images obtained 2 days later show progression of abnormalities (rectangles) at level of aortic arch (C) and ventricles (D), which now involve right upper and right and left lower lobe posterior zones. Credit: American Journal of Roentgenology (AJR)
Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Novel Coronavirus Imaging Shows “Significant Overlap” With SARS and MERS"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Although the imaging features of novel coronavirus disease 2019 (COVID-19) are variable and nonspecific, the findings reported thus far do show “significant overlap” with those of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), according to an ahead-of-print article in the American Journal of Roentgenology (AJR).

COVID-19 is diagnosed on the presence of pneumonia symptoms (e.g., dry cough, fatigue, myalgia, fever, dyspnea), as well as recent travel to China or known exposure, and chest imaging plays a vital role in both assessment of disease extent and follow-up.

As per her review of the present clinical literature concerning COVID-19, Melina Hosseiny of the University of California at Los Angeles concluded: “Early evidence suggests that initial chest imaging will show abnormality in at least 85% of patients, with 75% of patients having bilateral lung involvement initially that most often manifests as subpleural and peripheral areas of ground-glass opacity and consolidation.”

Furthermore, “older age and progressive consolidation” may imply an overall poorer prognosis.

Unlike SARS and MERS—where initial chest imaging abnormalities are more frequently unilateral—COVID-19 is more likely to involve both lungs on initial imaging.

“To our knowledge,” Hosseiny et al. continued, “pleural effusion, cavitation, pulmonary nodules, and lymphadenopathy have not been reported in patients with COVID-19.”

Ultimately, the authors of this AJR article recommended CT for follow-up in patients recovering from COVID-19 to evaluate long-term or even permanent pulmonary damage, including fibrosis—as seen in SARS and MERS infections.

Reference: Hosseiny, et al. (2020) Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. AJR DOI: https://www.ajronline.org/doi/10.2214/AJR.20.22969

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.